Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-K stay in one workspace.
LXRX
$1.79
-1.65%
LXRX
· Lexicon Pharmaceuticals, Inc.
$1.79
-0.03 (-1.65%)
At close · Nov 13
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$796.97M
Shares
445.23M
Volume · Nov 13
1.89M
Avg daily vol (3M)
2.62M
All webcasts
Earnings call · FY2024 Q4
Lexicon Pharmaceuticals, Inc. (LXRX) Q4 2024 Earnings Call
Revenue · derived Q4
$26.55M
+3688% YoY
Gross margin · derived Q4
98.7%
+8.7 pp YoY
Net income · derived Q4
-$33.77M
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Mar 6, 2025 · complete as-filed document
SEC periodic report
10-K report
Filed Mar 7, 2025 · complete as-filed document